Related Experiment Video
Updated: May 22, 2026

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
Published on: February 10, 2020
Patients with brain tumor-related epilepsy
Marta Maschio1, Loredana Dinapoli
1Center for Tumor-Related Epilepsy, Neurology Unit, Department of Neuroscience and Cervical-Facial Pathology, National Institute for Cancer "Regina Elena", Via Elio Chianesi 53, 00144, Rome, Italy. maschio@ifo.it
Patients with brain tumor-related epilepsy (BTRE) require a multidisciplinary approach. Customized treatment plans are essential for managing both the tumor and epilepsy, improving quality of life.
Area of Science:
- Neurology
- Oncology
- Pharmacology
Background:
- Brain tumor-related epilepsy (BTRE) presents a dual pathology, requiring specialized care.
- Epilepsy is a significant risk factor for long-term disability in brain tumor patients.
- BTRE management is complex due to drug resistance and impact on quality of life.
Purpose of the Study:
- To emphasize the need for a multidisciplinary and customized approach to managing brain tumor-related epilepsy.
- To highlight the challenges in antiepileptic drug selection for BTRE patients.
- To underscore the importance of seizure control for psychological and relational well-being.
Main Methods:
- Review of current therapeutic strategies for BTRE.
- Analysis of challenges in antiepileptic drug selection.
- Discussion of the impact of BTRE on patient quality of life and psychological state.
Main Results:
- BTRE necessitates a tailored treatment plan integrating oncological and antiepileptic therapies.
- Antiepileptic drug selection is complicated by drug resistance and significant quality of life impacts.
- Effective seizure control is crucial for the psychological and relational spheres of patients.
Conclusions:
- A multidisciplinary approach is vital for optimal BTRE patient management.
- Customized treatment plans, including emotional and psychological support, are essential.
- Addressing drug resistance and side effects is key to improving outcomes in BTRE.
More Related Videos
08:23A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016
09:57Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures l: Introduction
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...